SolarEdge names Gokul Krishnan SVP, general manager North America
Bitget2026/10/08 11:31SolarEdge Technologies named Gokul Krishnan senior vice president, general manager for North America, leading residential, commercial growth. Krishnan joins from Enphase Energy, most recently SVP and general manager of the consumer business unit. He previously led Enphase’s microinverter business unit, held business development roles, worked as COO at SunEdison’s residential unit. Krishnan succeeds Amir Cohen, who will support the transition while shifting to other initiatives. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SolarEdge Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610080730BIZWIRE_USPR_____20261008_BW497516) on October 08, 2026, and is solely responsible for the information contained therein.
- SolarEdge Technologies named Gokul Krishnan senior vice president, general manager for North America, leading residential, commercial growth.
- Krishnan joins from Enphase Energy, most recently SVP and general manager of the consumer business unit.
- He previously led Enphase’s microinverter business unit, held business development roles, worked as COO at SunEdison’s residential unit.
- Krishnan succeeds Amir Cohen, who will support the transition while shifting to other initiatives.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
